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Optimal Pulse Sequence for Ferumoxides-
Enhanced MR Imaging Used in the Detection
of Hepatocellular Carcinoma: A Comparative
Study Using Seven Pulse Sequences
Objective: To identify the optimal pulse sequence for ferumoxides-enhanced
magnetic resonance (MR) imaging in the detection of hepatocelluar carcinomas
(HCCs).
Materials and Methods: Sixteen patients with 25 HCCs underwent MR imaging
following intravenous infusion of ferumoxides. All MR studies were performed on a
1.5-T MR system, using a phased-array coil. Ferumoxides (Feridex IV) at a dose of
15  mol/Kg was slowly infused intravenously, and axial images of seven sequences
were obtained 30 minutes after the end of infusion. The MR protocol included fast
spin-echo (FSE) with two echo times (TR3333 8571/TE18 and 90-117), single-
shot FSE (SSFSE) with two echo times (TR /TE39 and 98), T2*-weighted gradi-
ent-recalled acquisition in the steady state (GRASS) (TR216/TE20), T2*-weighted
fast multiplanar GRASS (FMPGR) (TR130/TE8.4 9.5), and T2*-weighted fast mul-
tiplanar spoiled GRASS (FMPSPGR) (TR130/TE8.4 9.5). Contrast-to-noise ratios
(CNRs) of HCCs determined during the imaging sequences formed the basis of
quantitative analysis, and images were qualitatively assessed in terms of lesion
conspicuity and image artifacts. The diagnostic accuracy of all sequences was
assessed using receiver operating characteristic (ROC) analysis.
Results: Quantitative analysis revealed that the CNRs of T2*-weighted
FMPGR and T2*-weighted FMPSPGR were significantly higher than those of the
other sequences, while qualitative analysis showed that image artifacts were
prominent at T2*-weighted GRASS imaging. Lesion conspicuity was statistically
significantly less clear at SSFSE imaging. In term of lesion detection, T2*-weight-
ed FMPGR, T2*- weighted FMPSPGR, and proton density FSE imaging were
statistically superior to the others.
Conclusion: T2*-weighted FMPGR, T2*- weighted FMPSPGR, and proton
density FSE appear to be the optimal pulse sequences for ferumoxides-
enhanced MR imaging in the detection of HCCs.
erumoxides, superparamagnetic iron oxide particles coated with dextran,
is a tissue-specific magnetic resonance (MR) imaging contrast agent used
for the detection of hepatic tumors. Particulate substances administered
intravenously are cleared by phagocytosis of the reticuloendothelial system, including
the Kupffer cells of the liver, substantially shortening T2 of liver tissue (1, 2). Most fo-
cal hepatic lesions, particularly malignant tumors, are devoid of Kupffer cells, and fer-
umoxides improves contrast between lesions and liver tissue (3 5). In a recent study,
the conspicuity of nodular lesions in cirrhotic liver correlated closely with differences
in the number of Kupffer cells between liver parenchyma and nodular lesions (6).
Computed tomography during arterial portography (CTAP) is considered a highly
sensitive imaging modality for the preoperative detection of hepatic malignancy, with
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Freported sensitivities ranging from 81 to 93% (7 10).
Unfortunately, CTAP, despite its high sensitivity to the
presence of lesions, has major disadvantages: an invasive
procedure that necessitates angiography, and a high false-
positive rate (11). Ferumoxides-enhanced MR imaging has
been increasingly used for the detection of focal hepatic le-
sions, and the initial results have been encouraging (12
18). T2-weighted spin-echo (SE) and T2*-weighted gradi-
ent-echo (GRE) sequences are regarded optimal for the de-
tection of primary and secondary hepatic malignancies at
ferumoxides-enhanced MR imaging (1, 12, 15, 19 24). To
our knowledge, however, there have been few studies in-
volving the use of various pulse sequences such as newly
developed breath-hold, fast MR imaging techniques such as
single-shot fast SE (SSFSE), fast multiplanar gradient-re-
called acquisition in the steady state (GRASS) without
preparation pulses (FMPGR), and fast multiplanar spoiled
GRASS (FMPSPGR) (25, 26).
The purpose of this study was to identify the optimal
pulse sequence for the detection of hepatocelluar carcino-
ma (HCC) at ferumoxides-enhanced MR imaging.
MATERIALS AND METHODS
Patients
Between April and August 1999, 22 consecutive patients
underwent ferumoxides-enhanced MR imaging to assess
known or suspected focal liver lesions. The criteria for in-
clusion in this study were as follows: HCC was depicted at
contrast-enhanced CT, lesions were distributed in such a
way that they were resectable, and the patient was consid-
ered suitable for curative hepatic resection. On this basis,
five patients were excluded because HCCs were absent
(metastatic adenocarcinoma was found in two, and each of
cholangiocarcinoma, hepatic adenoma, and hemangioma in
one), and one other because HCCs were distributed dif-
fusely. The remaining 16 patients, 14 men and 2 women
ranging in age from 35 to 66 (mean, 51) years, with 25
HCCs (diameter, 3 140 [mean, 41] mm) in 24 hepatic seg-
ments comprised our final study group. Ferumoxides-en-
hanced MR imaging was not performed where patients
were pregnant, showed severe renal failure, or were aller-
gic to dextran-based drugs. The study was approved by the
institutional review board, and written informed consent
was obtained from all patients.
For 19 HCCs in 11 patients, diagnosis was based on the
histopathological findings of surgery; for two, on those of
US-guided percutaneous needle biopsy; and for the re-
maining four, the basis of confirmation was an elevated
serum  -fetoprotein level (over 200 ng/mL) and character-
istic helical CT findings. Thirteen patients in the study had
liver cirrhosis as a result of hepatitis B (n=12), or hepatitis
C (n=1), while the remaining three had hepatitis B without
cirrhosis. In order to evaluate hepatic segments which ac-
cording to the findings of ferumoxides-enhanced MR imag-
ing were HCC-free, follow-up radiologic examinations
(contrast-enhanced CT or gadolinium-enhanced MR imag-
ing) were performed no less than 12 months later. HCC
did not develop in those segments during the follow-up pe-
riod.
MR Imaging Examinations
All MR examinations were performed on a 1.5-T MR im-
ager (Horizon, GE Medical Systems, Milwaukee, Wis.,
U.S.A.) using a phased-array coil. Two respiratory-trig-
gered FSE sequences (TR3333 8571/TE18 and 90 117/
ETL12/NEX2/fat sat.), four breath-hold sequences (proton
density SSFSE [TR /TE39/NEX0.5], T2-weighted SSFSE
[TR /TE98/NEX0.5], FMPGR [TR130/TE8.4-9.5/flip an-
gle 30 ], and FMPSPGR [TR130/TE8.4 9.5/flip angle
30 ]), and the GRASS sequence (TR216/TE20/flip angle
60 ) were performed using the parameters shown in Table
1. Transverse sections were obtained with a rectangular
field of view (six-eight), a slice thickness of 6 8 mm, and
an interslice gap of 2 mm. To minimize motion artifact dur-
ing gradient-echo sequences, saturation bands superior and
inferior to the imaging volume were applied to all se-
quences. Fat saturation was used during proton density and
T2-weighted FSE and SSFSE sequences.
The patients underwent respiratory-triggered proton
density and T2-weighted FSE imaging, with repetition
times varying between 3,333 and 8,571, and between
3,240 and 8,620 msec, according to the period of the respi-
ratory cycle. At T2*-weighted FMPSPGR and FMPGR,
multiple sections were obtained in an interleaved fashion,
and the whole liver was covered with 20 sections using
two breath-holds.
Ferumoxides (Feridex IV; Advanced Magnetics Inc.,
Cambrige, Mass., U.S.A.) at a dose of 15  mol Fe/Kg was
diluted in 100 ml of 5% glucose solution and administrated
intravenously through an in-line 5- m specific filter over a
30-minute period. MR images were obtained 30 minutes
after the end of infusion.
Quantitative Imaging Analysis
The images obtained during each of the seven pulse se-
quences were quantitatively analysed using operator-de-
fined region-of-interest (ROI) measurements of the mean
signal intensity of liver parenchyma, lesions, and back-
ground noise. For the measurement of liver signal, ROIs
were set in areas devoid of focal changes in signal intensi-
ty, large vessels, and prominent artifact. If more than one
Kim et al.
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identified and measured at all sequences. For liver lesions,
circular or ovoid ROIs were drawn to encompass as much
of the lesion as possible. Noise was measured on each im-
age using ROIs positioned just ventral to the right anterior
abdominal wall; areas with the most prominent ghost were
not included. ROIs were drawn electrically, and were larg-
er than 256 mm
2 in the liver, 45 mm
2 in lesions, and 846
mm2 in the noise area; they were drawn three times in
each place and mean values were obtained. The lesion-to-
liver contrast-to-noise ratio (CNR) was calculated using the
following formula: (signal intensity lesion - signal intensity liv-
er)/standard deviation of background noise. Lesion-to-liver
CNR was compared statistically using Wilcoxon’s signed
ranks test.
Qualitative Imaging Analysis
Two readers unaware of the patients’ clinical data as-
sessed the image quality obtained during each of the seven
MR sequences. Each reader graded image quality as unac-
ceptable, poor, fair, good, or excellent (with numerical
scores of 1, 2, 3, 4, or 5, respectively) with regard to lesion
conspicuity and image artifacts (5 = absent). Inter-reader
agreement was assessed using a  statistic: a  score of
more than 0.60 was taken to indicate substantial to excel-
lent agreement (27). Discrepancies were resolved by con-
sensus between the readers, and the final ranking data
based on consensual interpretations were compared by
means of Wilcoxon’s signed ranks test.
ROC Analysis
All MR images of the 16 patients were randomized and
reviewed independently by three readers experienced in
MR imaging of the liver. For each pulse sequence, they
recorded the number, size, and segmental location of
HCCs. The name, age, identification number and imaging
parameters of each patient were masked to minimize
learning bias, and MR images of each pulse sequence were
reviewed on a segment-by-segment basis during sessions
separated by two weeks. To prevent mislocation of the le-
sion by the readers, hepatic segments were drawn directly
by the study coordinator according to Couinaud’s number-
ing system. A total of 128 hepatic segments were re-
viewed, including 24 segments with 25 HCCs. The readers
scored each image for the presence or absence of HCCs
and assigned one of five confidence levels, as follows: 1 =
definitely or almost definitely absent, 2 = probably absent,
3 = possibly present, 4 = probably present, 5 = definitely
or almost definitely present. When a lesion was located in
two or more segments, the readers were asked to consider
only the segment mainly involved and to assess the possi-
bility of another lesion in the other segment. A binomial
ROC curve was fitted to each reader’s confidence rating
using a maximum-likelihood estimation. The diagnostic ac-
curacy of each MR sequence determined by each reader
was evaluated by calculating the area under the ROC
curve (Az). Composite ROC curves that combined the per-
formance of all readers into a single curve were obtained
for each MR sequence, using the maximum-likelihood
curve-fitting algorithm to rate the pooled data of the three
readers (28, 29). The differences between MR sequences in
terms of mean Az were statistically analyzed using the
two-tailed Student t test. The relative sensitivity of each se-
quence was calculated according to the percentage of seg-
ments assigned a score of 3 or greater (‘possibly present’ to
‘definitely present’) among a total of 24 segments with
HCC. Relative specificity calculations were based on the
percentage of segments assigned a score of 1 or 2 among
93 segments without HCC. Using a  statistic, inter-reader
agreement regarding the detection of segments with HCC
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Table 1. Sequencing Parameters for MR Imaging of the Liver
Parameter FSE PD FSE T2 SSFSE PD SSFSE T2 GRASS T2* FMPGR T2* FMPSPGR T2*
TR (msec) 3,333 8,571 3,242 8,623 217 130 130
TE (msec) 17 99 39 98 20 8.5 8.5
ETL 12 12
Matrix (phase x frequency) 256 256 256 256 256 192 256 192 256 192 256 160 256 160
Field of view (mm) 32 24 32 24 32 24 32 24 32 24 32 24 32 24
Bandwidth (Hz per pixel) 120 120 160 160 83.3 60 60
No. of sections acquired 20 20 20 20 20 20 20
Acquisition time (sec) 225 241 23 26 168 41 41
No. of signals acquired 1 1 1111 1
Mode of signal acquired Multisection Multisection Sequential Sequential Multisection Multisection Multisection
Note. FSE = fast spin-echo, SSFSE = single-shot FSE, GRASS = gradient recalled acquisition in the steady state, FMPGR = fast multiplanar GRASS, 
FMPSPGR = fast multiplanar spoiled GRASS, PD = proton density, TR = time to repeat, TE = time to echo, ETL = echo train length Kim et al.
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Fig. 1. A 35-year-old man with a 6.0-cm hepatocellular carcinoma
(HCC) in segment V. Ferumoxides-enhanced proton density fast
spin-echo (FSE) (TR5000/TE18) (A), T2-weighted FSE (TR5000/
TE90) (B), proton density single-shot FSE (SSFSE) (TR /TE39)
(C), T2-weighted SSFSE (TR /TE98) (D), T2*-weighted gradient-
recalled acquisition in the steady state (GRASS) (TR216/TE20/flip
angle 60 ) (E), T2*-weighted fast multiplanar GRASS (FMPGR)
(TR130/TE8.4/flip angle 30 ) (F), and T2*-weighted fast multiplanar
spoiled GRASS (FMPSPGR) (TR130/TE8.4/flip angle 30 ) (G)
images show a discrete HCC with a high signal (arrows). T2*-
weighted FMPGR had the highest CNR (88.0), and T2*-weighted
FMPSPGR had the second highest CNR (83.0). The CNRs of
proton density FSE, T2-weighted FSE, T2*-weighted GRASS,
proton density SSFSE, and T2-weighted SSFSE were 72.5, 33.5,
33.0, 26.0, and 22.3, respectively.
EF
Gwas also assessed (27). Ten hepatic cysts were diagnosed
by sonography and CT, and excluded from analysis after
the review was complete.
RESULTS
Quantitative Analysis
The quantitative results of assessment of mean HCC-to-
liver CNR obtained during each pulse sequence are shown
in Table 2. The highest CNR was achieved with breath-
hold T2*-weighted FMPGR sequences (68.9 25.0); this
ratio was statistically significantly higher than those ob-
tained during all other sequences except breath-hold T2*-
weighted FMPSPGR (p < .05) (Fig. 1). The ratio obtained
during this sequence was the second highest and was statis-
tically significantly higher than those recorded during the
sequences ranked 4 to 7 (p < .05).
Qualitative Analysis
Table 3 summarizes the results of qualitative analysis for
each sequence. HCCs were statistically significantly clearer
at proton density and T2-weighted FSE, and at all three
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Fig. 2. A 41-year-old woman with a 2.8-cm HCC in segment VIII. T2-weighted FSE (A), T2-weighted SSFSE (B), T2*-weighted FMPGR
(C), and T2*-weighted FMPSPGR (D) images depict a high-signal HCC (arrow). The highest CNR (76.0) was seen at T2*-weighted
FMPGR imaging, while lesion conspicuity was significantly lower at SSFSE than at other sequences. 
CD
Table 2. HCC-to-Liver CNRs for Ferumoxides-Enhanced MR
Imaging Using Various Pulse Sequences
Sequence HCC-to-Liver CNR Rank
FSE PD 35.0 26.8 3
FSE T2 27.3 15.0 4
SSFSE PD 19.3 12.7 6
SSFSE T2 17.7 12.9 7
GRASS T2* 25.2 13.6 5
FMPGR T2* 68.9 25.0 1
FMPSPGR T2* 51.7 29.4 2
Note. Values were given as means SDs. There were significant (p<
.05) differences in HCC-to-liver CNR between the following comparisons
(numbers indicate rank): the sequence ranked 1 vs. those ranked 3 7,
and the sequence ranked 2 vs. those ranked 4 7. types of gradient-echo imaging than at the two SSFSE se-
quences (Fig. 2).
T2*-weighted GRASS imaging depicted imaging artifacts
more prominently than did the other six sequences, and
image interpretation was interfered with in 63% of cases
(10/16) (Table 3). T2*-weighted GRASS imaging demon-
strated pulsation artifacts due to heartbeat in all 16 pa-
tients (Fig. 3), motion-related artifacts were evident at pro-
ton density and T2-weighted FSE imaging in 63% (10/16)
and 50% (8/16), respectively. All T2*-weighted FMPGR
Kim et al.
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Fig.  3.  A  59-year-old  man  with  an  HCC  (not  shown).
Ferumoxides-enhanced T2*-weighted GRASS (A), T2*-weighted
FMPGR (B), and T2*-weighted FMPSPGR (C) images show
significant pulsation artifacts due to the heart and aorta.
Particularly at T2*-weighted GRASS imaging, the heartbeat
artifact may interfere with depiction of the lesion in the left hepatic
lobe. 
C
Table 3. Lesion Conspicuity and Imaging Artifacts for Ferumoxides-Enhanced MR Imaging Using Various Pulse Sequences
Sequence Lesion Conspicuity Rank Imaging Artifact Rank
FSE PD 4.61 0.89 4 4.00 0.52 5
FSE T2 4.74 0.54 2 4.18 0.66 3
SSFSE PD 3.74 1.10 6 4.25 0.58 2
SSFSE T2 3.61 1.03 7 4.56 0.51 1
GRASS T2* 4.57 0.95 5 3.25 0.58 7
FMPGR T2* 4.78 0.52 1 4.00 0.00 5
FMPSPGR T2* 4.74 0.62 2 4.06 0.25 4
Note. Values were given as means SDs. There were significant (p<.05) differences between the following comparisons (numbers indicate rank): the
sequences ranked 1 5 vs. those ranked 6, 7 for lesion conspicuity; the sequence ranked 1 vs. those ranked 2 7 for imaging artifacts; and the sequence
ranked 7 vs. those ranked 2 5 for imaging artifacts.and FMPSPGR imaging showed ghost artifacts due to aor-
tic pulsation in the phase-encoding direction, but proton
density and T2-weighted SSFSE imaging revealed no such
artifacts. Overall, the imaging artifacts of the six sequences
other than T2*-weighted GRASS were comparable. The
lowest  score for interobserver agreement between read-
ers was 0.712, and was for proton density SSFSE imaging
which depicted lesion conspicuity. Hence, agreement re-
garding lesion conspicuity and imaging artifacts was con-
sidered substantial to excellent for all sequences.
ROC Analysis
Table 4 shows the calculated areas under the ROC
curves and the mean area determined by the three readers
for each of the seven sequences. ROC curves drawn on the
basis of pooled data from the three readers for each of
these sequences are shown in Figure 4. With regard to le-
sion detection, two readers performed significantly better
with the T2*-weighted FMPGR, T2*- weighted FMPSPGR,
and proton density FSE sequences than the other four. One
reader’s interpretation of the seven sequences demonstrat-
ed no statistically significant differences in lesion detection.
In terms of integrated lesion detectability on the basis of
the pooled data reviewed by all observers, T2*-weighted
FMPGR, T2*- weighted FMPSPGR, and proton density
FSE imaging were statistically superior to those obtained
using the other sequences (Fig. 5). The mean areas under
the composite ROC curves of the three readers were 0.965
0.015 for T2*-weighted FMPGR sequences, 0.964
0.016 for T2*- weighted FMPSPGR, and 0.958 0.017 for
proton density FSE. 
The relative sensitivities of T2*-weighted FMPGR, T2*-
weighted FMPSPGR, and proton density FSE imaging
were superior to those obtained using the other sequences
(Table 5). Expressed as a percentage, the relative specifici-
ty of all sequences was 93 or more (Table 6). The lowest 
score for interobserver agreement was 0.690, and involved
T2-weighted FSE imaging between reader 2 and reader 3.
Agreement was thus considered substantial to excellent for
all sequences.
DISCUSSION
The acquisition of high-quality images in the shortest
possible time has been a major field of investigation in MR
imaging of the liver. According to recent reports, ferumox-
ides-enhanced MR imaging is useful for the detection of he-
patic tumors, including metastasis (5, 12, 15, 22) and HCCs
(3 5, 24), and investigators have also claimed that it is as
accurate as CTAP for detecting hepatic metastasis (12) or
HCC (11).
T2-weighted SE and T2*-weighted GRE are accepted fer-
umoxides-enhanced MR imaging sequences (13, 24, 30,
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Table 4. ROC for Ferumoxides-Enhanced MR Imaging Using Various Pulse Sequences: Results for Each Reader and All Readers
Sequence
Az
Az Rank (All Readers)
Reader 1 Reader 2 Reader 3 All Readers
FSE PD 0.931 0.037 0.977 0.022 0.969 0.025 0.958 0.017 3
FSE T2 0.916 0.040 0.971 0.024 0.893 0.045 0.924 0.022 6
SSFSE PD 0.866 0.049 0.959 0.029 0.860 0.050 0.894 0.026 7
SSFSE T2 0.933 0.036 0.954 0.030 0.905 0.042 0.928 0.022 4
GRASS T2* 0.915 0.040 0.950 0.032 0.914 0.041 0.925 0.022 5
FMPGR T2* 0.957 0.029 0.957 0.029 0.979 0.021 0.965 0.015 1
FMPSPGR T2* 0.964 0.016 0.955 0.030 0.979 0.021 0.964 0.016 2
Note. Values were given as means SDs. The Az differences between sequences ranked 1-3 and those ranked 4-7 were significant (p<.05).
Fig. 4. Graph showing composite receiver operating characteristic
(ROC) curves for pooled data reviewed by three observers. Areas
under ROC curves indicate the relative accuracy with which HCCs
were detected at ferumoxides-enhanced MR imaging obtained
during the seven sequences. T2*-weighted FMPGR, T2*-weighted
FMPSPGR, and proton density FSE were statistically superior to
the other sequences. According to the three readers, the mean
areas under the composite ROC curves were 0.965 0.015 for
the T2*-weighted FMPGR sequence, 0.964 0.016 for T2*-
weighted FMPSPGR, and 0.958 0.017 for proton density FSE,
respectively.
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False Positive Fraction31). At GRE imaging after intravenous ferumoxides ad-
ministration, signal loss of liver parenchyma is increased by
the presence of iron oxide particles because of its greater
susceptibility resulting from local field inhomogeneity (in-
travoxel dephasing) (21, 32). Fretz et al. (21) found that
GRE imaging with long TE and a narrow flip angle was an
ideal T2*-weighted sequence.
Yamamoto et al. (24) reported that HCC detection was
similar at ferumoxides-enhanced T2-weighted SE and GRE
imaging. In a study by Schwarz et al. (32), conventional SE
Kim et al.
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Fig. 5. A 60-year-old man with two HCCs measuring 0.6 cm and 0.3 cm in segment VIII. Ferumoxides-enhanced proton density FSE (A),
T2-weighted FSE (B), T2*-weighted FMPGR (C), and T2*-weighted FMPSPGR (D) images show two discrete, high-signal HCCs (large
arrow and small arrow). Proton density SSFSE (E) and T2-weighted SSFSE (F) images do not demonstrate these small lesions.
EFwas found to be superior to FSE due to the absence of a
180 refocusing pulse. However, because FSE sequences
are less sensitive to motion artifacts, and the decrease in
liver signal noted at FSE is comparable to that observed at
conventional SE, FSE sequences are, according to a recent
report (33), clinically useful for ferumoxides imaging. Van
Beers et al. (23) claimed that ferumoxides-enhanced GRE
imaging was as accurate as T2-weighted SE imaging for the
detection of malignant hepatic tumors and was superior for
determining their segmental location. However, the opti-
mal imaging sequence for lesion detection with ferumox-
ides enhancement is still open to debate.
Our results indicate that HCC-to-liver CNR was best at
T2*-weighted FMPGR sequence, for which the ratio was
statistically significantly higher than for all other sequences
except T2*-weighted FMPSPGR. One possible reason for
the lower CNR found with FSE and SSFSE imaging is that
a larger matrix is used for these sequences; this contributes
to the sharpness of lesion contour, but leads to low lesion-
to-liver CNR. The predominance of T2*-weighted imaging
is, however, thought to be caused mainly by local field in-
homogeneity and the lack of a refocusing pulse (21, 32).
Low CNR at T2*-weighted GRASS results from the high
noise level of this sequence.
Because of poor soft-tissue resolution due to the T2 fil-
tering effect, lesion conspicuity at SSFSE imaging was sta-
tistically significantly less clear than at other sequences.
Motion-related artifacts were significantly less severe with
T2-weighted and proton density SSFSE, T2*-weighted
FMPGR, and T2*-weighted FMPSPGR imaging, mainly be-
cause of their short acquisition time, which allows success-
ful breath-holding (34).
In terms of lesion-to-liver CNR, lesion conspicuity and
artifacts, T2*-weighted imaging was the best sequence,
though vascular structures and HCCs were similarly
demonstrated with a (bright) high signal. At FSE, on the
other hand, vascular structures were less bright than HCCs
(Figs. 1, 2, 5).
In ROC analysis, the area under the composite ROC
curve indicates performance. With regard to integrated le-
sion detectability, T2*-weighted FMPGR, T2*- weighted
FMPSPGR, and proton density FSE imaging were statisti-
cally superior to other sequences. The difference in perfor-
mance among MR sequences was more prominent for
small HCCs because these can demonstrate active uptake
of ferumoxides particles, which results in slight hyperinten-
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Table 6. The Specificity of Ferumoxides-Enhanced MR Imaging Using Various Pulse Sequences for the Identification of 93
Hepatic Segments without HCC
Sequence
Numbers of Segments Assigned a Score of 1 or 2 among 93 Segments without HCC
Reader 1 Reader 2 Reader 3 All Readers
FSE PD 90 (97) 89 (96) 91 0(98) 270 (97)
FSE T2 92 (99) 86 (93) 93 (100) 271 (97)
SSFSE PD 91 (98) 91 (98) 91 0(98) 273 (98)
SSFSE T2 92 (99) 86 (93) 90 0(97) 268 (96)
GRASS T2* 92 (99) 90 (97) 91 0(98) 273 (98)
FMPGR T2* 92 (99) 92 (99) 93 (100) 277 (99)
FMPSPGR T2* 91 (98) 92 (99) 93 (100) 276 (99)
Note. Numbers in parentheses indicate specificity expressed as a percentage.
Table 5. The Sensitivity of Ferumoxides-Enhanced MR Imaging Using Various Pulse Sequences for the Identification of 24
Hepatic Segments with HCC
Sequence
Numbers of Segments Assigned a Score of 3-5 among 24 Segments with HCC
Reader 1 Reader 2 Reader 3 All Readers
FSE PD 20 (83) 23 (96) 22 (92) 65 (90)
FSE T2 20 (83) 23 (96) 18 (75) 61 (85)
SSFSE PD 16 (67) 18 (75) 17 (71) 51 (71)
SSFSE T2 18 (75) 21 (88) 18 (75) 58 (81)
GRASS T2* 20 (83) 21 (88) 19 (79) 60 (83)
FMPGR T2* 22 (92) 22 (92) 23 (96) 67 (93)
FMPSPGR T2* 21 (88) 22 (92) 22 (92) 65 (90)
Note. Numbers in parentheses indicate sensitivity expressed as a percentage.sity, isointensity, or even hypointensity at ferumoxides-en-
hanced imaging (6).
Ferumoxides-enhanced MR imaging does not always fa-
cilitate differentiation between malignant tumors and be-
nign lesions. Oudkerk et al. (13) recommended T1-weight-
ed GRE (short TE) imaging after ferumoxides enhancement
in order to detect and characterize focal liver lesions. Cysts
can demonstrate low signal intensity at T1-weighted imag-
ing, and at ferumoxides-enhanced imaging, T1-weighted
sequences may permit good differentiation between malig-
nancy and cysts. Due to the T2 effect, however, cysts can
show high signal intensity at gradient-recalled echo se-
quences with long TE. According to Grangier et al., he-
mangiomas can be enhanced by shortening the T1 relax-
ation time at T1-weighted imaging after ferumoxides ad-
ministration (35). 
This study suffers certain limitations. First, while the
standard of reference is the findings of histopathological
analysis of 41 resected hepatic segments in 11 patients, fol-
low-up imaging findings were used as the standard of refer-
ence for 87 unresected segments. Second, in the segments
containing two hepatocelluar carcinomas or a hepatocellu-
ar carcinoma and a benign lesion (13%, n=3), segment-by-
segment analysis meant that comparisons for these particu-
lar lesions could not be made. Third, it was only in the de-
tection of HCCs that optimal pulse sequences for ferumox-
ides-enhanced MR imaging were evaluated: optimal se-
quences for the characterization of focal hepatic lesions
could not be determined. Finally, unenhanced MR imaging
was reported to be necessary in order to decrease the num-
ber of false-positive findings attributed to vascular struc-
tures. However, “biphasic” unenhanced and ferumoxides-
enhanced MR imaging is time consuming and such unen-
hanced imaging is thus not obtained (36). Without unen-
hanced imaging, we recorded few false-positive findings.
In conclusion, our results suggest that T2*-weighted
FMPGR, T2*-weighted FMPSPGR, and proton density FSE
sequences after intravenous ferumoxides administration
provide higher diagnostic accuracy than the other four se-
quences (T2-weighted SSFSE, T2*-weighted GRASS, T2-
weighted FSE, and proton density SSFSE), and show high-
er CNRs, fewer image artifacts and better lesion conspicu-
ity. For the detection of HCCs at ferumoxides-enhanced
MR imaging, they thus appear to be the optimal pulse se-
quences.
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